Periscope Capital’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-519,886
Closed -$22.1K 351
2024
Q2
$22.1K Sell
519,886
-598,364
-54% -$26.4K 0.01% 193
2024
Q1
$67.1K Hold
1,118,250
0.02% 194
2023
Q4
$55.9K Buy
1,118,250
+100,000
+10% +$4.57K 0.01% 239
2023
Q3
$76.2K Hold
1,018,250
0.01% 330
2023
Q2
$48.4K Buy
1,018,250
+114,000
+13% +$10.3K ﹤0.01% 436
2023
Q1
$109K Buy
+904,250
New +$104K 0.01% 432

Other funds holding NFYS.WS

Periscope Capital's NFYS.WS Position: Q3 2024 in Review

Periscope Capital sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2024, closing a stake of 519,886 shares — an estimated $22.1K sold.

Periscope Capital first reported a position in NFYS.WS in Q1 2023 and held it in 6 quarters. The position peaked at $109K in Q1 2023. 5 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2024.

  • Periscope Capital reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
  • Periscope Capital sold 519,886 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2024, an estimated $22.1K.
  • Periscope Capital first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2023 and held it in 6 quarters.
  • Periscope Capital's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $109K in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2024.

Based on Periscope Capital's 13F filing for Q3 2024, filed 12 Nov 2024.